New hope for tough prostate cancer: targeted drug trial launches
NCT ID NCT06970119
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests a new drug called INR102 in people with a specific type of advanced prostate cancer (PSMA-positive) that no longer responds to hormone therapy. The goal is to see if the drug is safe, how it moves through the body, and whether it can shrink tumors or lower PSA levels. About 55 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
NOT_YET_RECRUITINGWuxi, Jiangsu, 214000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tianjin Cancer Hospital Airport Hospital
RECRUITINGTianjin, Tianjin Municipality, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.